Back to Search Start Over

Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity.

Authors :
Pyle CJ
Labeur-Iurman L
Groves HT
Puttur F
Lloyd CM
Tregoning JS
Harker JA
Source :
The Journal of experimental medicine [J Exp Med] 2021 Dec 06; Vol. 218 (12). Date of Electronic Publication: 2021 Oct 19.
Publication Year :
2021

Abstract

T follicular helper cell (TFH)-dependent antibody responses are critical for long-term immunity. Antibody responses are diminished in early life, limiting long-term protective immunity and allowing prolonged or recurrent infection, which may be important for viral lung infections that are highly prevalent in infancy. In a murine model using respiratory syncytial virus (RSV), we show that TFH and the high-affinity antibody production they promote are vital for preventing disease on RSV reinfection. Following a secondary RSV infection, TFH-deficient mice had significantly exacerbated disease characterized by delayed viral clearance, increased weight loss, and immunopathology. TFH generation in early life was compromised by heightened IL-2 and STAT5 signaling in differentiating naive T cells. Neutralization of IL-2 during early-life RSV infection resulted in a TFH-dependent increase in antibody-mediated immunity and was sufficient to limit disease severity upon reinfection. These data demonstrate the importance of TFH in protection against recurrent RSV infection and highlight a mechanism by which this is suppressed in early life.<br />Competing Interests: Disclosures: H.T. Groves reported, "I am currently employed by the Wellcome Trust but I was not employed by the Wellcome Trust at the time of generating data for this research paper. I did not and do not have any role in the funding decisions behind the research included in the submitted work." J.S. Tregoning reported grants from MRC during the conduct of the study. No other disclosures were reported.<br /> (© 2021 Pyle et al.)

Details

Language :
English
ISSN :
1540-9538
Volume :
218
Issue :
12
Database :
MEDLINE
Journal :
The Journal of experimental medicine
Publication Type :
Academic Journal
Accession number :
34665220
Full Text :
https://doi.org/10.1084/jem.20201555